PATENT CLAIM ANALYSIS

Application Number: 16413719
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-11
Patent Classification: ["514", "184000"]

Abstract:
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein.

Claim (Index 16):
The pharmaceutical composition of  claim 6 , wherein the excipient has a weight percent of about 0.5% (w/w) to about 20% (w/w).

Metadata:
- Claim Count in Document: 23.0
- Percentile: 100.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14944610', '15179701', '14905537', '15737064', '12670257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7957743136689545
- 35 USC 102 Novelty (BERT): 0.5406282904392751
- Combined Prediction Score: 0.7702597113459866
- Mean Citation Score: 314.5987120000001
- Max Citation Score: 379.30566
- Similarity Product: 320.4243747969211

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test